Search Results - "BMC neurology"

Exercise prescription for patients with multiple sclerosis; potential benefits and practical recommendations by Halabchi, Farzin, Alizadeh, Zahra, Sahraian, Mohammad Ali, Abolhasani, Maryam

“…Multiple sclerosis (MS) can result in significant mental and physical symptoms, specially muscle weakness, abnormal walking mechanics, balance problems,…”
Get full text

The Cambridge Centre for Ageing and Neuroscience (Cam-CAN) study protocol: a cross-sectional, lifespan, multidisciplinary examination of healthy cognitive ageing by Shafto, Meredith A, Tyler, Lorraine K, Dixon, Marie, Taylor, Jason R, Rowe, James B, Cusack, Rhodri, Calder, Andrew J, Marslen-Wilson, William D, Duncan, John, Dalgleish, Tim, Henson, Richard N, Brayne, Carol, Matthews, Fiona E

“…As greater numbers of us are living longer, it is increasingly important to understand how we can age healthily. Although old age is often stereotyped as a…”
Get full text

Vitamin D deficiency as a risk factor for dementia and Alzheimer's disease: an updated meta-analysis by Chai, Bingyan, Gao, Fulin, Wu, Ruipeng, Dong, Tong, Gu, Cheng, Lin, Qiaoran, Zhang, Yi

“…We aimed to comprehensively explore the associations between serum 25(OH)D deficiency and risk of dementia and Alzheimer's disease(AD). We systematically…”
Get full text

Prevalence and burden of multiple sclerosis-related fatigue: a systematic literature review by Oliva Ramirez, Abril, Keenan, Alexander, Kalau, Olivia, Worthington, Evelyn, Cohen, Lucas, Singh, Sumeet

“…Multiple sclerosis (MS) is a chronic, demyelinating disease of the central nervous system that results in progressive and irreversible disability. Fatigue is…”
Get full text

Reperfusion therapy in acute ischemic stroke: dawn of a new era? by Bhaskar, Sonu, Stanwell, Peter, Cordato, Dennis, Attia, John, Levi, Christopher

“…Following the success of recent endovascular trials, endovascular therapy has emerged as an exciting addition to the arsenal of clinical management of patients…”
Get full text

Systematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosis by Meyer-Moock, Sandra, Feng, You-Shan, Maeurer, Mathias, Dippel, Franz-Werner, Kohlmann, Thomas

“…There are a number of instruments that describe severity and progression of multiple sclerosis and they are increasingly used as endpoints to assess the…”
Get full text

Clinical features, treatment and outcome in neurosarcoidosis: systematic review and meta-analysis by Fritz, Daan, van de Beek, Diederik, Brouwer, Matthijs C

“…Neurosarcoidosis is a rare variant of sarcoidosis and is only described in small cohort studies. We define clinical features, treatment and outcome of patients…”
Get full text

Validation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosis by Learmonth, Yvonne C, Motl, Robert W, Sandroff, Brian M, Pula, John H, Cadavid, Diego

“…The Patient Determined Disease Steps (PDDS) is a promising patient-reported outcome (PRO) of disability in multiple sclerosis (MS). To date, there is limited…”
Get full text

Acute encephalopathy with elevated CSF inflammatory markers as the initial presentation of COVID-19 by Farhadian, Shelli, Glick, Laura R, Vogels, Chantal B F, Thomas, Jared, Chiarella, Jennifer, Casanovas-Massana, Arnau, Zhou, Jing, Odio, Camila, Vijayakumar, Pavithra, Geng, Bertie, Fournier, John, Bermejo, Santos, Fauver, Joseph R, Alpert, Tara, Wyllie, Anne L, Turcotte, Cynthia, Steinle, Matthew, Paczkowski, Patrick, Dela Cruz, Charles, Wilen, Craig, Ko, Albert I, MacKay, Sean, Grubaugh, Nathan D, Spudich, Serena, Barakat, Lydia Aoun

“…COVID-19 is caused by the severe acute respiratory syndrome virus SARS-CoV-2. It is widely recognized as a respiratory pathogen, but neurologic complications…”
Get full text

The impact of physical exercise on the fatigue symptoms in patients with multiple sclerosis: a systematic review and meta-analysis by Razazian, Nazanin, Kazeminia, Mohsen, Moayedi, Hossein, Daneshkhah, Alireza, Shohaimi, Shamarina, Mohammadi, Masoud, Jalali, Rostam, Salari, Nader

“…Despite many benefits of the physical activity on physical and mental health of patients with Multiple Sclerosis (MS), the activity level in these patients is…”
Get full text

Survival and mortality in cerebral palsy: observations to the sixth decade from a data linkage study of a total population register and National Death Index by Blair, Eve, Langdon, Katherine, McIntyre, Sarah, Lawrence, David, Watson, Linda

“…Likely duration of survival of children described as having cerebral palsy is of considerable interest to individuals with cerebral palsy, their families,…”
Get full text

Incidence and prevalence of multiple sclerosis in Europe: a systematic review by Kingwell, Elaine, Marriott, James J, Jetté, Nathalie, Pringsheim, Tamara, Makhani, Naila, Morrow, Sarah A, Fisk, John D, Evans, Charity, Béland, Sarah Gabrielle, Kulaga, Sophie, Dykeman, Jonathan, Wolfson, Christina, Koch, Marcus W, Marrie, Ruth Ann

“…Multiple sclerosis (MS) is the most common cause of neurological disability in young adults worldwide and approximately half of those affected are in Europe…”
Get full text

Pediatric multiple sclerosis: a review by Alroughani, Raed, Boyko, Alexey

“…Pediatric-onset multiple sclerosis (POMS) prevalence and incidence rates are increasing globally. No disease-modifying therapy are approved for MS pediatric…”
Get full text

Trial design and rationale for APOLLO, a Phase 3, placebo-controlled study of patisiran in patients with hereditary ATTR amyloidosis with polyneuropathy by Adams, David, Suhr, Ole B, Dyck, Peter J, Litchy, William J, Leahy, Raina G, Chen, Jihong, Gollob, Jared, Coelho, Teresa

“…Patisiran is an investigational RNA interference (RNAi) therapeutic in development for the treatment of hereditary ATTR (hATTR) amyloidosis, a progressive…”
Get full text

A phase 3, long-term, open-label safety study of Galcanezumab in patients with migraine by Camporeale, Angelo, Kudrow, David, Sides, Ryan, Wang, Shufang, Van Dycke, Annelies, Selzler, Katherine J, Stauffer, Virginia L

“…Galcanezumab, a humanized monoclonal antibody that selectively binds to the calcitonin gene-related peptide, has demonstrated in previous Phase 2 and Phase 3…”
Get full text

Neurological manifestations and complications of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis by Yassin, Ahmed, Nawaiseh, Mohammed, Shaban, Ala, Alsherbini, Khalid, El-Salem, Khalid, Soudah, Ola, Abu-Rub, Mohammad

“…The spectrum of neurological involvement in COVID-19 is not thoroughly understood. To the best of our knowledge, no systematic review with meta-analysis and a…”
Get full text

Reliability, validity, and responsiveness of three scales for measuring balance in patients with chronic stroke by Alghadir, Ahmad H, Al-Eisa, Einas S, Anwer, Shahnawaz, Sarkar, Bibhuti

“…Various outcome measures are used for the assessment of balance and mobility in patients with stroke. The purpose of the present study was to examine…”
Get full text

Establishment of age group classification for risk stratification in glioma patients by Lin, Zhiying, Yang, Runwei, Li, Kaishu, Yi, Guozhong, Li, Zhiyong, Guo, Jinglin, Zhang, Zhou, Junxiang, Peng, Liu, Yawei, Qi, Songtao, Huang, Guanglong

“…Abstract Background Age is associated with the prognosis of glioma patients, but there is no uniform standard of age-group classification to evaluate the…”
Get full text

The misdiagnosis of prolonged disorders of consciousness by a clinical consensus compared with repeated coma-recovery scale-revised assessment by Wang, Jing, Hu, Xiaohua, Hu, Zhouyao, Sun, Ziwei, Laureys, Steven, Di, Haibo

“…Previous studies have shown that a single Coma-Recovery Scale-Revision (CRS-R) assessment can identify high rates of misdiagnosis by clinical consensus. The…”
Get full text

Ambroxol as a novel disease-modifying treatment for Parkinson's disease dementia: protocol for a single-centre, randomized, double-blind, placebo-controlled trial by Silveira, C R A, MacKinley, J, Coleman, K, Li, Z, Finger, E, Bartha, R, Morrow, S A, Wells, J, Borrie, M, Tirona, R G, Rupar, C A, Zou, G, Hegele, R A, Mahuran, D, MacDonald, P, Jenkins, M E, Jog, M, Pasternak, S H

“…Currently there are no disease-modifying treatments for Parkinson's disease dementia (PDD), a condition linked to aggregation of the protein α-synuclein in…”
Get full text